Synapse - Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation

Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation Journal Article

Authors:	Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Maloy, M. A.; O'Reilly, R. J.; Papadopoulos, E. B.; Peled, J. U.; Ponce, D. M.; Shaffer, B.; Tamari, R.; van den Brink, M. R. M.; Young, J. W.; Barba, P.; Perales, M. A.
Article Title:	Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation
Journal Title:	Advances in Cell and Gene Therapy
Volume:	4
Issue:	1
ISSN:	2573-8461
Publisher:	John Wiley & Sons
Date Published:	2021-01-01
Start Page:	e103
PMCID:	PMC9634849
PUBMED:	36339371
DOI:	10.1002/acg2.103
PROVIDER:	manual
Notes:	The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF. Corresponding MSK author is Christina Cho.